Tau PTM Profiles Identify Patient Heterogeneity and Stages of Alzheimer’s Disease DOI Creative Commons

Hendrik Wesseling,

Waltraud Mair,

Mukesh Kumar

et al.

Cell, Journal Year: 2020, Volume and Issue: 183(6), P. 1699 - 1713.e13

Published: Nov. 13, 2020

To elucidate the role of Tau isoforms and post-translational modification (PTM) stoichiometry in Alzheimer's disease (AD), we generated a high-resolution quantitative proteomics map 95 PTMs on multiple isolated from postmortem human tissue 49 AD 42 control subjects. Although PTM maps reveal heterogeneity across subjects, subset display high occupancy frequency for AD, suggesting importance disease. Unsupervised analyses indicate that occur an ordered manner, leading to aggregation. The processive addition minimal set associated with seeding activity was further defined by analysis size-fractionated Tau. summarize, features protein critical intervention at different stages are identified, including enrichment 0N 4R isoforms, underrepresentation C terminus, increase negative charge proline-rich region (PRR), decrease positive microtubule binding domain (MBD).

Language: Английский

Alzheimer's disease DOI
Philip Scheltens, Kaj Blennow, Monique M.B. Breteler

et al.

The Lancet, Journal Year: 2016, Volume and Issue: 388(10043), P. 505 - 517

Published: Feb. 25, 2016

Language: Английский

Citations

2748

A Liquid-to-Solid Phase Transition of the ALS Protein FUS Accelerated by Disease Mutation DOI Creative Commons
Avinash Patel, Hyun O. Lee, Louise Jawerth

et al.

Cell, Journal Year: 2015, Volume and Issue: 162(5), P. 1066 - 1077

Published: Aug. 1, 2015

Language: Английский

Citations

2712

The amyloid state and its association with protein misfolding diseases DOI
Tuomas P. J. Knowles, Michele Vendruscolo, Christopher M. Dobson

et al.

Nature Reviews Molecular Cell Biology, Journal Year: 2014, Volume and Issue: 15(6), P. 384 - 396

Published: May 23, 2014

Language: Английский

Citations

2215

Alzheimer's disease DOI Creative Commons
Chris Lane, John Hardy, Jonathan M. Schott

et al.

European Journal of Neurology, Journal Year: 2017, Volume and Issue: 25(1), P. 59 - 70

Published: Sept. 5, 2017

Alzheimer's disease, the commonest cause of dementia, is a growing global health concern with huge implications for individuals and society. In this review, current understanding epidemiology, genetics, pathology pathogenesis disease outlined, before its clinical presentation treatment strategies are discussed. Finally, review discusses how our enhanced Alzheimer pathogenesis, including recognition protracted preclinical phase, informing new therapeutic aim moving from to prevention.

Language: Английский

Citations

2047

Decoding ALS: from genes to mechanism DOI
J. Paul Taylor, Robert H. Brown, Don W. Cleveland

et al.

Nature, Journal Year: 2016, Volume and Issue: 539(7628), P. 197 - 206

Published: Nov. 8, 2016

Language: Английский

Citations

1821

How neuroinflammation contributes to neurodegeneration DOI
Richard M. Ransohoff

Science, Journal Year: 2016, Volume and Issue: 353(6301), P. 777 - 783

Published: Aug. 18, 2016

Neurodegenerative diseases such as Alzheimer's disease, Parkinson's amyotrophic lateral sclerosis, and frontotemporal lobar dementia are among the most pressing problems of developed societies with aging populations. Neurons carry out essential functions signal transmission network integration in central nervous system main targets neurodegenerative disease. In this Review, I address how neuron's environment also contributes to neurodegeneration. Maintaining an optimal milieu for neuronal function rests supportive cells termed glia blood-brain barrier. Accumulating evidence suggests that neurodegeneration occurs part because is affected during disease a cascade processes collectively neuroinflammation. These observations indicate therapies targeting glial might provide benefit those afflicted by disorders.

Language: Английский

Citations

1636

The New Neurometabolic Cascade of Concussion DOI
Christopher C. Giza,

David A. Hovda

Neurosurgery, Journal Year: 2014, Volume and Issue: 75(Supplement 4), P. S24 - S33

Published: Sept. 19, 2014

Since the original descriptions of postconcussive pathophysiology, there has been a significant increase in interest and ongoing research to study biological underpinnings concussion. The initial ionic flux glutamate release result energy demands period metabolic crisis for injured brain. These physiological perturbations can now be linked clinical characteristics concussion, including migrainous symptoms, vulnerability repeat injury, cognitive impairment. Furthermore, advanced neuroimaging allows window monitor postconcussion pathophysiology humans noninvasively. There is also increasing concern about risk chronic or even progressive neurobehavioral impairment after concussion/mild traumatic brain injury. Critical studies are underway better link acute pathobiology concussion with potential mechanisms cell death, dysfunction, neurodegeneration. This "new improved" article summarizes translational fashion updates what known neurometabolic changes concussive new connections proposed between this neurobiology early symptoms as well cellular processes that may underlie long-term

Language: Английский

Citations

1163

The Intersection of Amyloid Beta and Tau at Synapses in Alzheimer’s Disease DOI Creative Commons
Tara L. Spires‐Jones, Bradley T. Hyman

Neuron, Journal Year: 2014, Volume and Issue: 82(4), P. 756 - 771

Published: May 1, 2014

Language: Английский

Citations

1036

Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease DOI Open Access
Lawrence S. Honig, Bruno Vellas, Mark Woodward

et al.

New England Journal of Medicine, Journal Year: 2018, Volume and Issue: 378(4), P. 321 - 330

Published: Jan. 25, 2018

Alzheimer's disease is characterized by amyloid-beta (Aβ) plaques and neurofibrillary tangles. The humanized monoclonal antibody solanezumab was designed to increase the clearance from brain of soluble Aβ, peptides that may lead toxic effects in synapses precede deposition fibrillary amyloid.

Language: Английский

Citations

936

Fibril structure of amyloid-β(1–42) by cryo–electron microscopy DOI Open Access
Lothar Gremer,

Daniel Schölzel,

C. Schenk

et al.

Science, Journal Year: 2017, Volume and Issue: 358(6359), P. 116 - 119

Published: Sept. 8, 2017

Amyloids are implicated in neurodegenerative diseases. Fibrillar aggregates of the amyloid-β protein (Aβ) main component senile plaques found brains Alzheimer's disease patients. We present structure an Aβ(1-42) fibril composed two intertwined protofilaments determined by cryo-electron microscopy (cryo-EM) to 4.0-angstrom resolution, complemented solid-state nuclear magnetic resonance experiments. The backbone all 42 residues and nearly side chains well resolved EM density map, including entire N terminus, which is part cross-β resulting overall "LS"-shaped topology individual subunits. dimer interface protects hydrophobic C termini from solvent. characteristic staggering nonplanar subunits results markedly different ends, termed "groove" "ridge," leading binding pathways on both has implications for growth.

Language: Английский

Citations

919